Clinical Trials
Page 1 • 12 itemsAccess global clinical trial data, regulatory updates, and competitive intelligence for strategic pharma R&D and investment decisions.
ANVISA Clinical Trial Changes Brazil: What You Need to Know
Learn about the recent changes to ANVISA's clinical trial regulations in Brazil and how they impact drug development for various medical indications.
SAHPRA Accelerated Approval: What You Need to Know About Oncology Access
Learn how SAHPRA's Accelerated Approval is transforming oncology access, expediting vital treatments like Pembrolizumab for cancer patients in need.
African Medicines Agency impact: Harmonizing Clinical Trials in Africa
The African Medicines Agency is transforming clinical trials in Africa, streamlining processes for drug approvals and improving access to essential medicines.
ANVISA Clinical Trial Regulations: What Foreign Pharma Must Know in 2025
Learn essential insights on ANVISA's clinical trial regulations for 2025, crucial for foreign pharmaceutical companies navigating drug approvals in Brazil.
Decentralized Clinical Trials in LATAM: Growth, Challenges & Regulatory Insights
This article delves into the rise of decentralized clinical trials in LATAM, highlighting key growth factors, challenges faced, and essential regulatory insights.
HIV Treatment Clinical Trials Africa: Long-Acting Injectables & AMA Pathways
This article delves into HIV treatment clinical trials in Africa, highlighting long-acting injectables and the AMA pathways for enhanced patient care.
Adaptive Clinical Trial Designs: Impact on FDA Approval Pathways & Timelines
This article delves into the role of adaptive clinical trial designs in expediting FDA approval pathways, focusing on drug XYZ for chronic pain management.
Alzheimer's Clinical Trial Failures: Insights from Semaglutide & Posdinemab FDA Trials
This article delves into the recent failures of Alzheimer's clinical trials involving Semaglutide and Posdinemab, highlighting key insights and future directions.
CAR-T Therapy Clinical Trials: Insights from ASCO 2026 and FDA Approval Implications
Discover the latest insights on CAR-T therapy from ASCO 2026 and understand the potential implications of FDA approval for innovative cancer treatments.
FDA Guidance on Decentralized Clinical Trials: What You Need to Know
This article covers essential FDA guidance on decentralized clinical trials, focusing on their impact on drug development and patient engagement.
Alzheimer's Clinical Trial Failures: Novo Nordisk's Semaglutide Phase 3 Outcome & Market Impact
Novo Nordisk's Semaglutide Phase 3 trial for Alzheimer's has failed, raising concerns about future research and market dynamics in neurodegenerative treatments.
Clinical Trial Result Reporting Compliance in MEA: Global Registry Analysis
This article delves into the compliance of clinical trial result reporting for drug XYZ in the MEA region, highlighting insights from a global registry analysis.